These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 502079)

  • 1. Serum proteins in breast cancer.
    Alsabti EA; Muneir K
    Jpn J Exp Med; 1979 Aug; 49(4):235-40. PubMed ID: 502079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum protein changes in breast cancer: a prospective study.
    Pettingale KW; Tee DE
    J Clin Pathol; 1977 Nov; 30(11):1048-52. PubMed ID: 591643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Super-sensitive prostate-specific antigen (PSA) in serum of women with benign breast disease or breast cancer.
    Hautmann S; Huland E; Grupp C; Haese A; Huland H
    Anticancer Res; 2000; 20(3B):2151-4. PubMed ID: 10928169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast, gastric and colorectal cancer.
    Shimizu Y; Oshima K; Nakano Y; Fujita M; Taguchi T
    Biken J; 1981 Sep; 24(3):95-102. PubMed ID: 6175310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum protein fractions in patients with laryngeal cancer undergoing radiation therapy. Possibility as a prognostic factor].
    Onizuka K; Migita S; Yamada H; Matsumoto I
    Fukuoka Igaku Zasshi; 1999 Feb; 90(2):46-58. PubMed ID: 10199063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer.
    Niwa Y; Akamatsu H; Niwa H; Sumi H; Ozaki Y; Abe A
    Clin Cancer Res; 2001 Feb; 7(2):285-9. PubMed ID: 11234881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
    Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
    Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific serum protein levels in women using intrauterine contraceptive device.
    Wiedermann D; Kríz J; Cídl K
    Czech Med; 1980; 3(3):239-47. PubMed ID: 6969168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CA 125 measurement in the follow-up of breast cancer patients.
    Böhmer C; Jäger W; Lang N
    Anticancer Res; 1997; 17(4B):3099-100. PubMed ID: 9329610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up study in breast cancer patients using serum tumor markers CEA and CA 15-3.
    Lumachi F; Brandes AA; Boccagni P; Polistina F; Favia G; D'Amico DF
    Anticancer Res; 1999; 19(5C):4485-9. PubMed ID: 10650797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of serum prolactin determination in metastatic breast cancer patients.
    Mujagić Z; Mujagić H
    Croat Med J; 2004 Apr; 45(2):176-80. PubMed ID: 15103755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
    Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of hepatocyte growth factor in patients with breast cancer.
    Sheen-Chen SM; Liu YW; Eng HL; Chou FF
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy protein-1 in the serum of patients with diseases of the breast].
    Strache RR; Briese V; Szabo DG; Than GN; Kunze M; Richter D
    Zentralbl Gynakol; 1987; 109(5):274-9. PubMed ID: 3035827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
    Zhang GJ; Adachi I
    Anticancer Res; 1999; 19(2B):1427-32. PubMed ID: 10365118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of TPA in breast cancer.
    Madeddu G; Farris A; Casu AR; Saiu MA; Eriu R; Costanza C; Arras ML; Costanza C; Campus S
    Cancer Detect Prev; 1985; 8(1-2):47-52. PubMed ID: 4064051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
    Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
    J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients.
    Giai M; Roagna R; Ponzone R; Biglia N; Sgro L; Perona M; Sismondi P
    Anticancer Res; 1996; 16(2):875-81. PubMed ID: 8687144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.